Bladder cancer study: testing a tool to see if womb and ovaries can be saved
Part of Cancer clinical trials.
This trial is testing a decision-making tool to help women with bladder cancer choose whether to keep their uterus, ovaries, and other pelvic organs during bladder removal surgery. It may help maintain quality of life after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman 18 years or older with bladder cancer that started in the lining of the bladder (urothelial cancer).
- You need to be scheduled for surgery to remove your bladder (radical cystectomy) and be well enough for that surgery.
- You must be able to have an MRI of your pelvis (a special scan) before surgery.
- You should have at least one of these organs still present: front part of the vagina, uterus, fallopian tubes (at least one), or ovaries.
- You cannot have cancer that has spread to other parts of your body (metastatic) or other active cancers that could affect study results.
- You must not be pregnant or breastfeeding, and if you could become pregnant, you must use birth control during the study and for 12 weeks after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
This trial studies whether a “prostate-sparing” radical cystectomy is safe and effective for bladder cancer patients who are having surgery. It aims to see if this approach can treat bladder cancer while reducing prostate-related side effects.
This trial uses a lab-grown version of your tumor (an organoid) to see which chemotherapy might work best for you after bladder cancer surgery. It helps doctors choose the most effective treatment for each person.
This trial tests if adding a special CT scan before bladder removal helps find muscle-invasive bladder cancer earlier. It includes people with different stages of bladder cancer who are planning to have their bladder removed.
This trial tests if using a patient's own tumor cells grown in a lab (organoids) can help choose the best chemotherapy to put directly into the bladder. It is for people with non-muscle invasive bladder cancer who need their first round of this treatment.
This trial tests a new robotic system to remove bladder tumors in one piece (en-bloc resection) for people with early-stage, non-muscle invasive bladder cancer. It may offer a more precise surgical option for eligible patients.
Hear when a new Urothelial Carcinoma Bladder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.